Article info

Download PDFPDF
Extended report
Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study

Authors

  • Jeffrey R Curtis Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA PubMed articlesGoogle scholar articles
  • Fenglong Xie Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA PubMed articlesGoogle scholar articles
  • Lang Chen Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA PubMed articlesGoogle scholar articles
  • Kenneth G Saag Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA PubMed articlesGoogle scholar articles
  • Huifeng Yun Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA PubMed articlesGoogle scholar articles
  • Paul Muntner Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jeffrey R Curtis, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; jrcurtis{at}uabmc.edu
View Full Text

Citation

Curtis JR, Xie F, Chen L, et al
Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study

Publication history

  • Received May 3, 2017
  • Revised October 31, 2017
  • Accepted November 2, 2017
  • First published December 21, 2017.
Online issue publication 
February 12, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.